Zostavax rush sparks shortage in three states

Elderly Australians have embraced the subsidised shingles vaccine to the point where there’s a shortage in three states, the distributor has confirmed.

At least 190,000 people have been vaccinated since 1 November when Zostavax (Seqirus, MSD) was rolled out for 70- to 79-year-olds under the National Immunisation Program.

Victoria, South Australia and Queensland have been experiencing shortages but new stock will be distributed this week, according to Dr Lorna Meldrum, Seqirus vice-president commercial operations, Asia Pacific.

The manufacturer, Merck, is giving priority to fulfilling Australian